摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-nitro-4-[(1E)-2-nitro-1-butenyl]benzene | 49678-62-8

中文名称
——
中文别名
——
英文名称
1-nitro-4-[(1E)-2-nitro-1-butenyl]benzene
英文别名
1-Nitro-4-(2-nitrobut-1-en-1-yl)benzene;1-nitro-4-[(E)-2-nitrobut-1-enyl]benzene
1-nitro-4-[(1E)-2-nitro-1-butenyl]benzene化学式
CAS
49678-62-8
化学式
C10H10N2O4
mdl
——
分子量
222.2
InChiKey
WFOBQJIBZWZLLZ-VQHVLOKHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    91.6
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    1-nitro-4-[(1E)-2-nitro-1-butenyl]benzene 在 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene on polystyrene.HL 、 polystyrene supported 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine 作用下, 以 四氢呋喃二氯甲烷异丙醇 为溶剂, 生成 tert-butyl 4-ethyl-1-(4-methoxybenzyl)-3-(4-nitrophenyl)-1H-pyrrole-2-carboxylate
    参考文献:
    名称:
    Clean five-step synthesis of an array of 1,2,3,4-tetra-substituted pyrroles using polymer-supported reagents
    摘要:
    聚合物支撑试剂及其他固态捕获剂可用于合成一系列1,2,3,4-四取代吡咯衍生物,无需任何色谱纯化步骤。
    DOI:
    10.1039/a809345h
  • 作为产物:
    参考文献:
    名称:
    Clean five-step synthesis of an array of 1,2,3,4-tetra-substituted pyrroles using polymer-supported reagents
    摘要:
    聚合物支撑试剂及其他固态捕获剂可用于合成一系列1,2,3,4-四取代吡咯衍生物,无需任何色谱纯化步骤。
    DOI:
    10.1039/a809345h
点击查看最新优质反应信息

文献信息

  • A convenient synthesis and cytotoxic evaluation of β-aryl-α-methylidene-γ-lactones and β-aryl-α-methylidene-γ-lactams
    作者:Anna Albrecht、Łukasz Albrecht、Marek Różalski、Urszula Krajewska、Anna Janecka、Kazimierz Studzian、Tomasz Janecki
    DOI:10.1039/b9nj00740g
    日期:——
    3-Aryl-2-diethoxyphosphoryl-4-nitrohexanoates 8, obtained by Michael addition of ethyl diethoxyphosphorylacetate 6 to 1-aryl-2-nitro-1-butenes 7, were utilized as convenient common intermediates in the synthesis of β-aryl-γ-ethyl-α-methylidene-γ-lactones 17 and β-aryl-γ-ethyl-α-methylidene-γ-lactams 21. Transformation of the nitro functionality in 8 into a hydroxyl or amino group and cyclization yielded lactones 16 or lactams 19, which were used in Horner–Wadsworth–Emmons olefination of formaldehyde to give target compounds in good yields. Cytotoxicity of these compounds was evaluated in vitro against mouse leukemia cell line L-1210 and two human leukemia cell lines, HL-60 and NALM-6. Two of the obtained compounds 17b,c with 4-bromophenyl and 4-methylphenyl substituents in the β position proved to be very potent against all three cell lines with IC50 values lower than 6 μM.
    在合成δ-芳基-δ-乙基-±-亚甲基-δ-内酯 17 和δ-芳基-δ-乙基-±-亚甲基-δ-内酰胺 21 的过程中,将 3-芳基-2-二乙氧基酰-4-硝基己酸酯 8 作为方便的通用中间体,通过迈克尔法将二乙氧基乙酸乙酯 6 加到 1-芳基-2-硝基-1-丁烯 7 中得到。将 8 中的硝基官能团转化为羟基或基并进行环化,可得到内酯 16 或内酰胺 19,将其用于霍纳-沃兹沃斯-艾蒙斯甲醛烯化反应,可得到收率很高的目标化合物。这些化合物对小鼠白血病细胞株 L-1210 和两种人类白血病细胞株 HL-60 和 NALM-6 的细胞毒性进行了体外评估。事实证明,在δ位置上具有 4-溴苯基和 4-甲基苯基取代基的两种化合物 17b 和 c 对所有三种细胞株都有很强的抑制作用,其 IC50 值低于 6 ¼M。
  • Androgen receptor antagonists
    申请人:Furuya Shuichi
    公开号:US20050101657A1
    公开(公告)日:2005-05-12
    The present invention provides an androgen receptor antagonistic agent and a superior prophylactic or therapeutic agent for hormone-sensitive cancer, which contain a compound of the formula: wherein, R 1 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, R 2 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, R 3 is a hydrogen atom, a hydrocarbon group which may have substituent(s), an acyl group or a heterocyclic group which may have substituent(s), R 4 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, and R 5 is a cyclic group which may have substituent(s); or a salt thereof, or its prodrug.
    本发明提供了一种雄激素受体拮抗剂,以及一种优越的预防或治疗激素敏感性癌症的药物,其含有式中的化合物:其中,R1是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过原子结合的基团,R2是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过原子结合的基团,R3是氢原子、可能具有取代基的碳氢基团、酰基或可能具有取代基的杂环基团,R4是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过原子结合的基团,R5是可能具有取代基的环状基团;或其盐或前药。
  • Amine-Free O-Sulfonylation by a Combination of 4-Methylpyridine N-Oxide Catalyst with 4Å Molecular Sieves
    作者:Keisuke Yoshida、Yuma Matsumoto、Juo Masuda、Shinji Kitagaki
    DOI:10.1055/a-1865-2970
    日期:2022.9
    An amine-free sulfonylation of various alcohols was developed that uses 4-methylpyridine N-oxide in the presence of 4Å molecular sieves at room temperature. This mild method gives various sulfonylated products in high yields, and can be applied to base-sensitive substrates.
    在室温下,在 4Å 分子筛存在下,使用 4-甲基吡啶N-氧化物开发了各种醇的无胺磺酰化。这种温和的方法以高收率得到各种磺酰化产物,可应用于碱敏感底物。
  • ANDROGEN RECEPTOR ANTAGONISTS
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1466902A1
    公开(公告)日:2004-10-13
    The present invention provides an androgen receptor antagonistic agent and a superior prophylactic or therapeutic agent for hormone-sensitive cancer, which contain a compound of the formula: wherein, R1 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom; R2 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, R3 is a hydrogen atom, a hydrocarbon group which may have substituent (s) , an acyl group or a heterocyclic group which may have substituent(s), R4 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, and R5 is a cyclic group which may have substituent(s); or a salt thereof, or its prodrug.
    本发明提供了一种雄激素受体拮抗剂和一种激素敏感性癌症的高级预防或治疗剂,其中含有一种式化合物: 其中,R1 是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过原子结合的基团;R2 是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合 的基团或通过原子结合的基团; R3 是氢原子、烃基,该烃基可能具有取代基(s)、R4 是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过原子结合的基团,R5 是可能带有取代基的环状基团;或其盐或其原药。
  • Supported organic catalysts: synthesis of ( E )-nitrostyrenes from nitroalkanes and aromatic aldehydes over propylamine supported on MCM-41 silica as a reusable catalyst
    作者:Giuseppina Demicheli、Raimondo Maggi、Alessandro Mazzacani、Paolo Righi、Giovanni Sartori、Franca Bigi
    DOI:10.1016/s0040-4039(01)00156-3
    日期:2001.3
    MCM-41-supported propylamine showed high catalytic efficiency in the nitroaldol condensation between nitroalkanes and aromatic aldehydes. (C) 2001 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫